5225.KLSE IHH Healthcare Bhd
- Market cap
- MYR 69.4B
- P/E
- 31.4x
- P/B
- 2.21x
- ROE
- 7.0%
- Dividend yield
- 1.34%
- Fundamental score
- 2.0/5
Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.
Is 5225.KLSE undervalued?
Graham number5225.KLSE trades 75.6% above its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
IHH Healthcare Bhd fundamental analysis
9 of 22 checks passedROE 0/2
Low return on equity (7.0%), below 10%.
ROA 0/1
Return on assets (3.7%) is below the industry median (3.7%).
Profit Consistency 2/2
Profitable for 10 consecutive years.
Earnings Growth 5Y 1/1
Earnings per share grew over the past 5 years.
Earnings Acceleration 0/1
Last year's EPS growth (-21.1%) is not above the 5-year average (60.0% a year).
Earnings Growth vs Industry 0/1
Last year's EPS growth (-21.1%) is below the industry median (6.1%).
Revenue Growth 2/2
Revenue grew 12.7% a year over the past 3 years.
Short-term Liquidity 0/1
Current assets do not cover short-term liabilities.
Long-term Liabilities 0/1
Current assets do not cover long-term liabilities.
Debt to Equity 1/2
Moderate debt to equity (48.5%), up to 100%.
Debt Trend 1/1
Debt to equity has not risen over the past 5 years.
Debt Coverage 1/1
Operating cash flow covers 20% of total debt.
Interest Coverage 0/1
EBIT is 4.2x against interest expense, below 5x.
PE vs Market 0/1
PE (31.4x) is above the market median (11.4x).
PE vs Industry 0/1
PE (31.4x) is above the industry median (27.9x).
PBV 0/1
Price to book (2.2x) is above the industry median (2.2x).
Graham Number 0/1
The price is above the Graham number (PE x PB = 69.4, limit 22.5).
PEG 1/1
PEG on 5-year earnings growth is 0.52, growth is cheap.
Dividend Yield 0/2
Dividend yield (1.3%) is in the bottom 25% of dividend payers in the market.
Dividend Stability 0/2
Dividends were not paid steadily for the past 5 years.
Dividend Growth 1/1
Dividends paid grew over the past 5 years.
Payout Ratio 1/1
Payout ratio is 44.1%, covered by earnings.
Each check is worth 1 or 2 points by how much it says about the quality of the company. The score is the share of points earned, out of 5. Ask AI to explain this score
About IHH Healthcare Bhd
IHH Healthcare Berhad, an investment holding company, provides healthcare services in Singapore, Malaysia, India, Greater China, Japan, Türkiye and Europe, and internationally. The company offers primary care services, such as outpatient treatment, check-ups, vaccinations, preventive care, and patient education services; secondary and tertiary care services, including medical emergencies and acute treatment, diagnostics and lab services; quaternary services comprising specia…
Full company profileIHH Healthcare Bhd financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 2 quarters up to Jun 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
IHH Healthcare Bhd annual financial statements (MYR; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 10.0B | 11.1B | 11.5B | 14.9B | 13.4B | 17.1B | 18.0B | 20.9B | 24.4B | 25.7B | 27.2B |
| Gross Profit | 7.33B | 8.13B | 8.36B | 10.4B | 9.30B | 12.0B | 12.5B | 14.7B | 17.6B | 6.63B | 13.0B |
| Operating Income | 1.38B | 1.80B | 1.54B | 1.69B | 974M | 2.59B | 2.70B | 4.26B | 4.03B | 3.35B | 3.83B |
| EBITDA | 1.88B | 2.45B | 2.00B | 2.94B | 2.45B | 4.32B | 4.10B | 6.28B | 6.28B | 5.24B | 6.44B |
| Net Income | 612M | 970M | 628M | 551M | 199M | 1.86B | 1.55B | 2.95B | 2.66B | 2.10B | 2.20B |
| EPS | 0.07 | 0.12 | 0.08 | 0.06 | 0.02 | 0.21 | 0.18 | 0.34 | 0.30 | 0.24 | 0.25 |
| Balance Sheet | |||||||||||
| Total Assets | 37.2B | 38.9B | 45.1B | 45.1B | 44.5B | 45.5B | 48.5B | 51.3B | 56.8B | 57.6B | 58.8B |
| Total Liabilities | 13.3B | 13.0B | 16.6B | 17.0B | 17.5B | 18.2B | 19.3B | 18.9B | 22.9B | 23.5B | 23.6B |
| Shareholders' Equity | 22.0B | 24.0B | 24.2B | 24.5B | 23.9B | 24.6B | 26.2B | 29.1B | 30.1B | 30.3B | 31.3B |
| Cash & Short-term Investments | 2.59B | 6.08B | 8.11B | 5.06B | 4.61B | 5.36B | 2.08B | 2.67B | 2.32B | 2.29B | 1.90B |
| Total Debt | 7.49B | 7.64B | 10.6B | 11.1B | 11.6B | 10.9B | 10.8B | 10.0B | 14.8B | 15.5B | 15.2B |
| Cash Flow | |||||||||||
| Operating Cash Flow | 1.93B | 2.26B | 1.86B | 2.45B | 2.44B | 3.53B | 3.67B | 3.42B | 4.29B | 5.05B | 4.53B |
| Capital Expenditure | 2.29B | 1.51B | 1.06B | 1.08B | 904M | 1.07B | 1.72B | 1.94B | 3.24B | 3.45B | 3.19B |
| Free Cash Flow | -354M | 755M | 803M | 1.37B | 1.54B | 2.46B | 1.95B | 1.48B | 1.05B | 1.61B | 1.34B |
| Ratios | |||||||||||
| ROE | 2.8% | 4.0% | 2.6% | 2.3% | 0.8% | 7.6% | 5.9% | 10.1% | 8.8% | 6.9% | 7.0% |
| ROA | 1.6% | 2.5% | 1.4% | 1.2% | 0.4% | 4.1% | 3.2% | 5.8% | 4.7% | 3.6% | 3.7% |
| Net Profit Margin | 6.1% | 8.7% | 5.4% | 3.7% | 1.5% | 10.9% | 8.6% | 14.1% | 10.9% | 8.2% | 8.1% |
| Debt to Equity | 0.34x | 0.32x | 0.44x | 0.45x | 0.49x | 0.44x | 0.41x | 0.35x | 0.49x | 0.51x | 0.48x |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
IHH Healthcare Bhd dividends
- Dividend yield
- 1.34%
- Forward dividend
- 0.11 MYR
- Payout ratio
- 44.1%
- Ex-dividend date
- Sep 29, 2026
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | MYR 927M | 0.10 | 44.1% |
| 2024 | MYR 881M | 0.10 | 33.2% |
| 2023 | MYR 1.77B | 0.20 | 60.0% |
| 2022 | MYR 528M | 0.06 | 34.1% |
| 2021 | MYR 351M | 0.04 | 18.9% |
| 2020 | MYR 351M | 0.04 | 176.3% |
| 2019 | MYR 263M | 0.03 | 47.7% |
| 2018 | MYR 247M | 0.03 | 39.4% |
| 2017 | MYR 247M | 0.03 | 25.5% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Who owns IHH Healthcare Bhd
- Insiders 38.73%
- Institutions 51.72%
- Public & others 9.55%
- Shares outstanding 8.84B
- Free float 3.13B
IHH Healthcare Bhd company profile
- Company name
- IHH Healthcare Bhd
- Ticker
- 5225.KLSE
- ISIN
- MYL5225OO007
- Exchange
- Kuala Lumpur Exchange
- Sector
- Healthcare
- Industry
- Health Care Providers & Services
- Employees
- 76,000
- Fiscal year end
- December
- Address
- Mercu Aspire, Kuala Lumpur, Malaysia, 59200
- Phone
- 60 3 2201 0138
- Website
- ihhhealthcare.com
About IHH Healthcare Bhd
IHH Healthcare Berhad, an investment holding company, provides healthcare services in Singapore, Malaysia, India, Greater China, Japan, Türkiye and Europe, and internationally. The company offers primary care services, such as outpatient treatment, check-ups, vaccinations, preventive care, and patient education services; secondary and tertiary care services, including medical emergencies and acute treatment, diagnostics and lab services; quaternary services comprising specialist consultative care, advanced treatment, complex surgery, and inpatient care services; and quaternary care services, such as organ transplants, neurosurgery, cardiac surgery, and reconstructive plastic surgery; and complementary ancillary services. It also engages in the provision of catering, laundry, and cleaning services for hospitals, as well as services of preparation and serving food; supervise and manage the construction of healthcare facilities; conduct research, develop, and market healthcare information systems, web-based applications, and other technology solutions; e-consulting and marketplace activities relating to all health-related products; import and wholesale of drug and medical materials; and operates pharmacy. In addition, the company provides facility management and building maintenance; clinical research; rehabilitation; administrative support; comprehensive professional oncological services, such as diagnostic, radiotherapy, and chemotherapy treatment; courses in nursing and allied health; agent and administrator for managed care and related services; and computer software designing development, customization, integration, implementation, maintenance, and related services. Further, it is involved in development, construction, and leasing of medical facility buildings; retail sale of pharmaceutical, medical, and orthopaedic goods; and property development. IHH Healthcare Berhad was incorporated in 2010 and is based in Kuala Lumpur, Malaysia.
IHH Healthcare Bhd management
10- Dr. Prem Kumar NairGroup Chief Executive Officer · born 1961
- Mr. Dilip KadambiGroup Chief Financial Officer · born 1974
- Ms. Ida Suryati binti Ab RahimGroup General Counsel · born 1973
- Ms. Sook Yean FooGroup Chief Human Resource Officer · born 1972
- Ms. Nili Shayrina binti SaatGroup Chief Risk Officer · born 1975
- Mr. Stephen John ByrneGroup Chief Internal Audit Officer · born 1973
- Mr. Ashok PanditGroup Chief Corporate Officer · born 1965
- Dr. Chorng Ann ChowChief Executive Officer of IHH Healthcare Singapore · born 1975
- Dr. Hing Lim TsangRegional Chief Executive Officer of IHH Healthcare North Asia · born 1970
- Associate Prof. Hsiu Chin LimGroup Chief Medical Officer · born 1974